<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The treatment of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (MDSs) continues to be challenging and difficult to standardize </plain></SENT>
<SENT sid="1" pm="."><plain>This article describes a decision tree for the treatment of MDSs based on age, presence or absence of a potential HLA-identical donor, and prognostic factors including bone marrow blast proportion, severity of cytopenias, and karyotype </plain></SENT>
</text></document>